A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma.
about
Diagnostic workup and management of patients with suspected Niemann-Pick type C diseaseSterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patientsNiemann-Pick disease type C symptomatology: an expert-based clinical descriptionGenetic and laboratory diagnostic approach in Niemann Pick disease type CCollaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 diseaseDysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseasesImpaired cholesterol efflux in senescent macrophages promotes age-related macular degenerationPre-symptomatic activation of antioxidant responses and alterations in glucose and pyruvate metabolism in Niemann-Pick Type C1-deficient murine brainNiemann-Pick C disease gene mutations and age-related neurodegenerative disordersThe hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease.Miglustat: a review of its use in Niemann-Pick disease type C.Tracking the subcellular fate of 20(s)-hydroxycholesterol with click chemistry reveals a transport pathway to the Golgi.Adaptations of energy metabolism associated with increased levels of mitochondrial cholesterol in Niemann-Pick type C1-deficient cells.Diagnosis of Niemann-Pick disease type C with 7-ketocholesterol screening followed by NPC1/NPC2 gene mutation confirmation in Chinese patientsNiemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrinPsychiatric signs and symptoms in treatable inborn errors of metabolism.Early steps in steroidogenesis: intracellular cholesterol trafficking.Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1)Cholesterol in brain disease: sometimes determinant and frequently implicated.Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective studyA murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele.A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease.Niemann-Pick Type C-2 Disease: Identification by Analysis of Plasma Cholestane-3β,5α,6β-Triol and Further Insight into the Clinical Phenotype.Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database.Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency.Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1.Cholesterolomics: An updateQuantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight.A rare case of Niemann-Pick disease type C without neurological involvement in a 66-year-old patient.Detection and confirmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometry.Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicatorsRelationship between serum polyunsaturated fatty acids and pregnancy in women undergoing in vitro fertilization.Efficacy of N-acetylcysteine in phenotypic suppression of mouse models of Niemann-Pick disease, type C1.A Suspicion Index to aid screening of early-onset Niemann-Pick disease Type C (NP-C)Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profilingEstablishing the precise evolutionary history of a gene improves prediction of disease-causing missense mutations.Genetic screening for Niemann-Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study.Identification of novel bile acids as biomarkers for the early diagnosis of Niemann-Pick C disease.Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease.
P2860
Q26748586-12B15A07-AC23-4716-895F-4C45A453AFE9Q26765783-31067164-970D-48CE-A4EB-CCD7BF2E1FEAQ26860273-092DC600-74E8-48BA-875F-5386801C8F82Q26999301-EC61C54F-8CD1-4BAC-8A13-CF128D4CAC50Q27006029-BE4D7D95-076C-4366-B4D1-45DC59DC1D67Q27009984-CA414D37-1E7D-4216-860E-BEA5D1B1452EQ28288496-2700AF16-A317-4A37-8761-967F91CA332AQ28393157-6BB6CF01-1DAA-4FF4-BA79-AAA7D5616CC4Q28538079-481EF9E8-C8E5-4677-8B8B-903E24B72019Q30235362-262B8B1D-8CFF-4F6F-A04A-9D681688B522Q33460275-74477E37-6A23-4EF6-8B47-008734F0699DQ33676201-870D8387-089F-4238-A0BA-9B0646B1EE81Q33718519-945AB057-F1D1-4408-B895-B830BABD040CQ33763605-FF3F2DFB-15DB-4B97-98D3-7A6989ACB112Q33945068-9657EA72-A89F-424C-B4D8-28A93E4FBC95Q34076774-1FD16B92-3ADF-4425-967A-65D3F60F01CEQ34221799-7FEC619C-80C1-483E-90C0-AB4CEA741588Q34379062-DA6BD6BD-3AC7-4561-AA8D-B039E2511318Q34621446-FCA3A94E-2E9F-47E5-8868-E3B7C4EEB3C2Q34640755-0122EA1D-4D3A-4363-A98A-98E8295D7127Q35649458-E4C119E5-7809-4227-9F0E-347CD349DB5EQ35775542-4133B4B6-7AF2-4189-9EED-6E84CD014CFBQ35795421-3DF69217-E096-4053-996A-5677169E5939Q35868559-EE5CEEF1-9FFA-4D4F-ABF4-CF1358EC200FQ36093226-222B838A-C4AF-4B5F-BCB9-C31E1B5EE7FAQ36122424-70BB0729-E4B0-4240-B319-EF7CE9134304Q36248727-969CAA22-68D9-4A27-A561-A15060B76E7CQ36249577-1FAEFBA6-78A8-41BA-8021-8BF60A817412Q36353769-FDFA2DE3-FE02-4218-8CC1-355BF16978DBQ36571707-C1878E72-B0DA-426D-96FD-320480EB37F9Q36731791-2BA06ADE-55A4-4B11-8BDB-F6994A18E40EQ36831584-9309806E-AFE6-4443-B8A8-6A03C2F5D889Q37071254-07B56053-FC7B-445C-A83E-6B4A87EC624EQ37078859-4312AD84-529A-44D3-A4DC-FF48F094DF3FQ37119427-345E8E13-8152-4633-BE0B-C16550FC2D8FQ37163059-4A6D95B8-9523-4B39-AF55-835279B2AF10Q37187970-0E2B8BE0-B4FA-4FF8-8845-D663E9F71029Q37220691-BA93032A-8AA7-49D0-8D09-8AA4A0358552Q37384927-55CB082F-EB08-4077-B2D3-F03BE99676CEQ37457283-A849987E-A577-4E21-9EE8-4334FA0AE43E
P2860
A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
A sensitive and specific LC-MS ...... C1 disease from human plasma.
@ast
A sensitive and specific LC-MS ...... C1 disease from human plasma.
@en
type
label
A sensitive and specific LC-MS ...... C1 disease from human plasma.
@ast
A sensitive and specific LC-MS ...... C1 disease from human plasma.
@en
prefLabel
A sensitive and specific LC-MS ...... C1 disease from human plasma.
@ast
A sensitive and specific LC-MS ...... C1 disease from human plasma.
@en
P2093
P2860
P50
P356
P1476
A sensitive and specific LC-MS ...... C1 disease from human plasma.
@en
P2093
Daniel S Ory
Danielle Taylor te Vruchte
David E Scherrer
Dennis J Dietzen
Forbes D Porter
Hideji Fujiwara
Jean E Schaffer
Jessie Zhang
Nicole M Yanjanin
Xuntian Jiang
P2860
P304
P356
10.1194/JLR.D015735
P577
2011-04-24T00:00:00Z